Consultation display
Inquiry into Stroke Risk Reduction: follow up inquiry
- This consultation has completed. It ran from Tuesday, 23 July 2013 to Wednesday, 23 October 2013
- View the background to this consultation
- View all current consultations
Response to the consultation
Evidence submitted in response to this Consultation
- SFU 1 - Mayberry Pharmacy
PDF 5 MB - SFU 2 - BMA Cymru Wales PDF 527 KB
- SFU 3 - Royal Pharmaceutical Society PDF 247 KB View as HTML (4) 21 KB
- SFU 4 - Powys Teaching Health Board PDF 59 KB View as HTML (5) 11 KB
- SFU 5 - Aneurin Bevan University Health Board PDF 112 KB View as HTML (6) 62 KB
- SFU 6 - BMS-Pfizer Alliance PDF 433 KB View as HTML (7) 48 KB
- SFU 7 - Royal College of Physicians PDF 1004 KB
- SFU 8 - Royal College of Nursing Wales PDF 144 KB View as HTML (9) 26 KB
- SFU 9 - Cwm Taf Health Board PDF 159 KB View as HTML (10) 50 KB
- SFU 10 - Stroke Association PDF 156 KB View as HTML (11) 36 KB
- SFU 11 - Anticoagulation Europe PDF 109 KB View as HTML (12) 16 KB
- SFU 12 - Atrial Fibrillation Association PDF 159 KB View as HTML (13) 46 KB
- SFU 13 - Welsh Stroke Alliance PDF 85 KB View as HTML (14) 46 KB
- SFU 14 - Public Health Wales PDF 565 KB View as HTML (15) 29 KB
- SFU 15 - Cardiff & Vale University Health Board PDF 46 KB
Purpose of the consultation
The
National Assembly for Wales’ Health
and Social Care Committee undertook follow-up work on the one-day inquiry into stroke risk
reduction it reported on in December 2011.
To
inform its work, the Committee contacted those who submitted evidence to the
original inquiry to ask for any evidence of progress in relation to the
recommendations made in the 2011 Report, and where progress is still required
The
consultation has now closed.
Supporting documents
Contact details
Should you wish to speak to someone regarding this consultation, please use the below contact details:
Health and Social Care Committee - Fourth Assembly
Welsh Parliament
Cardiff Bay
Cardiff
CF99 1SN
Email: Contact@senedd.wales
Telephone: 0300 200 6565